{"id":752886,"date":"2023-05-01T07:18:29","date_gmt":"2023-05-01T11:18:29","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-first-quarter-2023-financial-results-on-may-15-2023\/"},"modified":"2023-05-01T07:18:29","modified_gmt":"2023-05-01T11:18:29","slug":"cara-therapeutics-to-announce-first-quarter-2023-financial-results-on-may-15-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-first-quarter-2023-financial-results-on-may-15-2023\/","title":{"rendered":"Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, 2023"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">STAMFORD, Conn., May  01, 2023  (GLOBE NEWSWIRE) &#8212; Cara Therapeutics, Inc.\u00a0(Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced the Company will host a conference call and live audio webcast on Monday, May 15, 2023, at 4:30 p.m. ET to report first quarter 2023 financial results and provide a corporate update.<\/p>\n<p align=\"justify\">To participate in the conference call, please register <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HYRJ_sejIc6XN0z9V2OaAUHhaPN52MieZJuaIMQ6-C0IRasWEwjqg5kphHcHJttWseRoyzlbyAGH_oxJGront73b3ydkKOjoySfgeoX9j2GfJ-spC5_xr358CDL9sziYfkVg5kHyaTDG316tTFeACQ==\" rel=\"nofollow noopener\" target=\"_blank\">here<\/a>. Registrants will receive the dial-in numbers and a unique PIN.<\/p>\n<p align=\"justify\">A live audio webcast and archived replay of the call will be available under \u201cEvents &amp; Presentations\u201d in the News &amp; Investors section of the Company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uULMDlxCqVjaUmfNu_GeCwbOC3xM6aD_8dEHSdvN8VQV5t3Z2q9-vsFPzzVjCllRIlUV9xK3zRFW0iLEASShXFJT-RM0LDijUlt466n6KoM=\" rel=\"nofollow noopener\" target=\"_blank\">www.CaraTherapeutics.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>About Cara Therapeutics<\/strong>\n      <\/p>\n<p align=\"justify\">Cara Therapeutics\u00a0is a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus. The Company\u2019s KORSUVA\u00ae (difelikefalin) injection is the first and only FDA-approved treatment for moderate-to-severe pruritus associated with chronic kidney disease in adults undergoing hemodialysis. The Company is developing an oral formulation of difelikefalin and has Phase 3 programs ongoing for the treatment of pruritus in patients with non-dialysis dependent advanced chronic kidney disease and atopic dermatitis. In addition, the Company has initiated a Phase 2\/3 program of oral difelikefalin for the treatment of moderate-to-severe pruritus in patients with notalgia paresthetica. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uULMDlxCqVjaUmfNu_GeCwbOC3xM6aD_8dEHSdvN8VT9TVmzec7PWlyt3A2xG3gxMs2XEtS9k0v5CRJEfBQt4qpGugz6tIp2auePHUvyTzc=\" rel=\"nofollow noopener\" target=\"_blank\">www.CaraTherapeutics.com<\/a> and follow the company on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oXQGynzbzG9Pgx_ykWkqGZ9EkqsgUF-3IA3k180Pp_9EKB8FD8Wn2QKn_9g6xWmcJsDJ3g2k1n1LtzQVqyn4pw==\" rel=\"nofollow noopener\" target=\"_blank\">Twitter<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NMleZFQBbpgPGA3YDUHcAepB-BDLorgbNgqLuaG_anr0Wmp3oMqTGgYzfaku7UdmNIgWUNoSRzotmjC2eTcJe6D-ZEq01Y7oOx7jTZo6OsZJhHiQE6RqWxKKU-rvRW5A\" rel=\"nofollow noopener\" target=\"_blank\">LinkedIn<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6ckQya9FE598aPdJ6UjkK9WGPyCGdowPdH9WCMQdccTMpRKA3T7ERLrXsrZBKUCsGZ3aPGMGVaoncTkmWyNo4GERHEqNeVbOC-LhXzfC9xiaBxZq5_yJGzZtWTFA9llS\" rel=\"nofollow noopener\" target=\"_blank\">Instagram<\/a>.<\/p>\n<p>\n        <strong>MEDIA CONTACT:<\/strong><br \/>\n        <br \/>Annie Spinetta<br \/>6 Degrees<br \/>973-768-2170<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dU9j7dJaQbKbeInCCAa6FVMsGxIKMn5gA6U8XJ2B4Sp58nsYXk8bmVO8ib7ebvo_tUvzfQAiwCQ3fIXXtEqBZGUOi8HZBs0P8j7MZscww0o=\" rel=\"nofollow noopener\" target=\"_blank\"><u>aspinetta@6degreespr.com<\/u><\/a><\/p>\n<p>\n        <strong>INVESTOR CONTACT:<\/strong><br \/>\n        <br \/>Iris Francesconi, Ph.D.<br \/>Cara Therapeutics<br \/>203-406-3700<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=827jZ2Hifs4LDLzM_OQFKlRT4Y_onX8Q4mztS6gMN1SVK9az163hMnP1iDGavxPtMxOIQogHS4DRsRxX2MJXU-l6K72uUews9d42vKGzS8hcuSTLEUYTapdVY0K429IQ\" rel=\"nofollow noopener\" target=\"_blank\"><u>investor@caratherapeutics.com<\/u><\/a><\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyODIyNCM1NTY0NTExIzIwMDYwMzk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NTI4MjcwNmUtZmRjZC00NWY2LTk3MTUtMjQ0MGUxOWZlMzIwLTEwMTc2MTI=\/tiny\/Cara-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>STAMFORD, Conn., May 01, 2023 (GLOBE NEWSWIRE) &#8212; Cara Therapeutics, Inc.\u00a0(Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced the Company will host a conference call and live audio webcast on Monday, May 15, 2023, at 4:30 p.m. ET to report first quarter 2023 financial results and provide a corporate update. To participate in the conference call, please register here. Registrants will receive the dial-in numbers and a unique PIN. A live audio webcast and archived replay of the call will be available under \u201cEvents &amp; Presentations\u201d in the News &amp; Investors section of the Company\u2019s website at www.CaraTherapeutics.com. About Cara Therapeutics Cara Therapeutics\u00a0is a commercial-stage biopharmaceutical &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-first-quarter-2023-financial-results-on-may-15-2023\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, 2023&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-752886","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-first-quarter-2023-financial-results-on-may-15-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"STAMFORD, Conn., May 01, 2023 (GLOBE NEWSWIRE) &#8212; Cara Therapeutics, Inc.\u00a0(Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced the Company will host a conference call and live audio webcast on Monday, May 15, 2023, at 4:30 p.m. ET to report first quarter 2023 financial results and provide a corporate update. To participate in the conference call, please register here. Registrants will receive the dial-in numbers and a unique PIN. A live audio webcast and archived replay of the call will be available under \u201cEvents &amp; Presentations\u201d in the News &amp; Investors section of the Company\u2019s website at www.CaraTherapeutics.com. About Cara Therapeutics Cara Therapeutics\u00a0is a commercial-stage biopharmaceutical &hellip; Continue reading &quot;Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, 2023&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-first-quarter-2023-financial-results-on-may-15-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-01T11:18:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyODIyNCM1NTY0NTExIzIwMDYwMzk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cara-therapeutics-to-announce-first-quarter-2023-financial-results-on-may-15-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cara-therapeutics-to-announce-first-quarter-2023-financial-results-on-may-15-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, 2023\",\"datePublished\":\"2023-05-01T11:18:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cara-therapeutics-to-announce-first-quarter-2023-financial-results-on-may-15-2023\\\/\"},\"wordCount\":263,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cara-therapeutics-to-announce-first-quarter-2023-financial-results-on-may-15-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyODIyNCM1NTY0NTExIzIwMDYwMzk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cara-therapeutics-to-announce-first-quarter-2023-financial-results-on-may-15-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cara-therapeutics-to-announce-first-quarter-2023-financial-results-on-may-15-2023\\\/\",\"name\":\"Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cara-therapeutics-to-announce-first-quarter-2023-financial-results-on-may-15-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cara-therapeutics-to-announce-first-quarter-2023-financial-results-on-may-15-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyODIyNCM1NTY0NTExIzIwMDYwMzk=\",\"datePublished\":\"2023-05-01T11:18:29+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cara-therapeutics-to-announce-first-quarter-2023-financial-results-on-may-15-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cara-therapeutics-to-announce-first-quarter-2023-financial-results-on-may-15-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cara-therapeutics-to-announce-first-quarter-2023-financial-results-on-may-15-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyODIyNCM1NTY0NTExIzIwMDYwMzk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyODIyNCM1NTY0NTExIzIwMDYwMzk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cara-therapeutics-to-announce-first-quarter-2023-financial-results-on-may-15-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-first-quarter-2023-financial-results-on-may-15-2023\/","og_locale":"en_US","og_type":"article","og_title":"Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, 2023 - Market Newsdesk","og_description":"STAMFORD, Conn., May 01, 2023 (GLOBE NEWSWIRE) &#8212; Cara Therapeutics, Inc.\u00a0(Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced the Company will host a conference call and live audio webcast on Monday, May 15, 2023, at 4:30 p.m. ET to report first quarter 2023 financial results and provide a corporate update. To participate in the conference call, please register here. Registrants will receive the dial-in numbers and a unique PIN. A live audio webcast and archived replay of the call will be available under \u201cEvents &amp; Presentations\u201d in the News &amp; Investors section of the Company\u2019s website at www.CaraTherapeutics.com. About Cara Therapeutics Cara Therapeutics\u00a0is a commercial-stage biopharmaceutical &hellip; Continue reading \"Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-first-quarter-2023-financial-results-on-may-15-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-05-01T11:18:29+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyODIyNCM1NTY0NTExIzIwMDYwMzk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-first-quarter-2023-financial-results-on-may-15-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-first-quarter-2023-financial-results-on-may-15-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, 2023","datePublished":"2023-05-01T11:18:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-first-quarter-2023-financial-results-on-may-15-2023\/"},"wordCount":263,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-first-quarter-2023-financial-results-on-may-15-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyODIyNCM1NTY0NTExIzIwMDYwMzk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-first-quarter-2023-financial-results-on-may-15-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-first-quarter-2023-financial-results-on-may-15-2023\/","name":"Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-first-quarter-2023-financial-results-on-may-15-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-first-quarter-2023-financial-results-on-may-15-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyODIyNCM1NTY0NTExIzIwMDYwMzk=","datePublished":"2023-05-01T11:18:29+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-first-quarter-2023-financial-results-on-may-15-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-first-quarter-2023-financial-results-on-may-15-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-first-quarter-2023-financial-results-on-may-15-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyODIyNCM1NTY0NTExIzIwMDYwMzk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyODIyNCM1NTY0NTExIzIwMDYwMzk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-first-quarter-2023-financial-results-on-may-15-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/752886","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=752886"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/752886\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=752886"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=752886"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=752886"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}